Onconetix (Onconetix) 6-1 Month Momentum % : -49.35% (As of May. 29, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Onconetix 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-29), Onconetix's 6-1 Month Momentum % is -49.35%.

The industry rank for Onconetix's 6-1 Month Momentum % or its related term are showing as below:

ONCO's 6-1 Month Momentum % is ranked worse than
87.94% of 1518 companies
in the Biotechnology industry
Industry Median: -5.095 vs ONCO: -49.35

Competitive Comparison of Onconetix's 6-1 Month Momentum %

For the Biotechnology subindustry, Onconetix's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onconetix's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onconetix's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Onconetix's 6-1 Month Momentum % falls into.

Onconetix (NAS:ONCO) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %

( Price 1-month ago

Price 6-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onconetix (NAS:ONCO) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Onconetix 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Onconetix's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Onconetix (Onconetix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onconetix Inc (NAS:ONCO) » Definitions » 6-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

J4T:Germany

Address

201 East Fifth Street, Suite 1900, Cincinnati, OH, USA, 45202

Website

https://www.onconetix.com

Onconetix Inc is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. It has a product named Entadfi an FDA approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Executives

Neil J Campbell	director, officer: Chief Executive Officer	225 CHIMNEY CORNER LANE, SUITE 2001, JUPITER FL 33458
Bruce Harmon	officer: Chief Financial Officer	316 DEL PRADO BLVD. S., SUITE 204, CAPE CORAL FL 33990
Timothy R. Ramdeen	director	201 E. FIFTH STREET SUITE 1900, CINCINNATI OH 45202
Vuk Jeremic	director	BLUE WATER VACCINES INC., 201 E. FIFTH STREET, SUITE 1900, CINCINNATI OH 45202
Cincinnati Cornerstone Investors Bwv I, Llc	10 percent owner	2900 READING ROAD, SUITE 410, CINCINNATI OH 45206
Cincinnati Cornerstone Capital Llc	other: Manager-Cinti Cornerstone Inv.	2900 READING RD, SUITE 410, CINCINNATI OH 45206
Joseph Hernandez	10 percent owner, officer: CEO	C/O MICROLIN BIO, INC., NEW YORK NY 10022
Simon Tarsh	director	201 E. FIFTH STREET SUITE 1900, CINCINNATI OH 45202
Allan Shaw	director	C/O CELSUS THERAPEUTICS PLC, 24 WEST 40TH STREET, NEW YORK NY 10018
Erin Henderson	officer: Chief Business Officer	201 E. FIFTH STREET, SUITE 1900, CINCINNATI OH 45202
James Sapirstein	director	1517 SAN JACINTO, HOUSTON TX 77002
Kimberly M Murphy	director	101 EAST KENNEDY BLVD., SUITE 2800, TAMPA FL 33602
Rice John Mccune Jr.	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jon Garfield	officer: CFO	11111 SANTA MONICA BLVD., SUITE 650, LOS ANGELES CA 90025
Michael Venerable	director	201 E. FIFTH STREET, SUITE 1900, CINCINNATI OH 45202